Clinical Trials

At any given time, more than a dozen clinical trials are underway at University Hospitals Seidman Cancer Center for patients with lymphoma. These trials expand the range of therapeutic options available, from patients who are newly diagnosed to those who have relapsed after one, two, or more lines of treatment.

The scope of our clinical research includes trials designed for patients of different ages and across various types of lymphomas, with the goal of establishing a broad spectrum of treatment approaches tailored to disease characteristics and individual patient needs. First-in-human clinical studies offer patients who have exhausted other treatment options access to emerging therapies.

Across this extensive portfolio of clinical trials and therapeutic development throughout our health system, researchers aim to transform lymphoma care by improving clinical outcomes and long-term prognosis.